Cargando…

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Detalles Bibliográficos
Autores principales: Yu, Kaikai, Liu, Bin, Yu, Haotian, Sun, Chengbiao, Wang, Xuefeng, Li, Guorui, Dong, Mingxin, Wang, Yan, Zhang, Jianxu, Xu, Na, Liu, Wensen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484629/
https://www.ncbi.nlm.nih.gov/pubmed/37692173
http://dx.doi.org/10.3389/fcimb.2023.1264974
_version_ 1785102622267539456
author Yu, Kaikai
Liu, Bin
Yu, Haotian
Sun, Chengbiao
Wang, Xuefeng
Li, Guorui
Dong, Mingxin
Wang, Yan
Zhang, Jianxu
Xu, Na
Liu, Wensen
author_facet Yu, Kaikai
Liu, Bin
Yu, Haotian
Sun, Chengbiao
Wang, Xuefeng
Li, Guorui
Dong, Mingxin
Wang, Yan
Zhang, Jianxu
Xu, Na
Liu, Wensen
author_sort Yu, Kaikai
collection PubMed
description
format Online
Article
Text
id pubmed-10484629
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104846292023-09-08 Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022 Yu, Kaikai Liu, Bin Yu, Haotian Sun, Chengbiao Wang, Xuefeng Li, Guorui Dong, Mingxin Wang, Yan Zhang, Jianxu Xu, Na Liu, Wensen Front Cell Infect Microbiol Cellular and Infection Microbiology Frontiers Media S.A. 2023-08-24 /pmc/articles/PMC10484629/ /pubmed/37692173 http://dx.doi.org/10.3389/fcimb.2023.1264974 Text en Copyright © 2023 Yu, Liu, Yu, Sun, Wang, Li, Dong, Wang, Zhang, Xu and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Yu, Kaikai
Liu, Bin
Yu, Haotian
Sun, Chengbiao
Wang, Xuefeng
Li, Guorui
Dong, Mingxin
Wang, Yan
Zhang, Jianxu
Xu, Na
Liu, Wensen
Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
title Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
title_full Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
title_fullStr Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
title_full_unstemmed Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
title_short Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
title_sort corrigendum: a neutralizing bispecific single-chain antibody against sars-cov-2 omicron variant produced based on cr3022
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484629/
https://www.ncbi.nlm.nih.gov/pubmed/37692173
http://dx.doi.org/10.3389/fcimb.2023.1264974
work_keys_str_mv AT yukaikai corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT liubin corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT yuhaotian corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT sunchengbiao corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT wangxuefeng corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT liguorui corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT dongmingxin corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT wangyan corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT zhangjianxu corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT xuna corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022
AT liuwensen corrigendumaneutralizingbispecificsinglechainantibodyagainstsarscov2omicronvariantproducedbasedoncr3022